Position in ZTS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$5,145,247
-$3,203,688 QoQ
Shares Held
71,601
+1.4% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#332
of 1,408 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026New York Life Investment Management LLC holds $14,583,179 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (35.3% of the industry book) .
All Filings in ZTS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,145,247 | 71,601 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $8,348,935 | 70,628 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $8,292,041 | 65,904 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $9,516,945 | 65,042 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $10,406,075 | 66,727 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $10,989,564 | 66,745 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $11,020,422 | 67,639 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $13,149,855 | 67,304 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $12,187,554 | 70,302 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $11,829,808 | 69,912 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $14,265,903 | 72,280 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $12,527,603 | 72,006 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $12,518,460 | 72,693 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $12,266,794 | 73,701 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $10,813,484 | 73,787 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $10,988,140 | 74,099 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $12,851,527 | 74,766 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||